Longboard Pharmaceuticals financials at a glance
| Year | Year | 2021 | 2022 | 2023 | 2020 | 2024 | |
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-1.93 | $-2.56 | $-2.39 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | -0.00% | 0 | 0 |
| Sha. | Shares |
|
16.87m | 17.22m | 0m | 0m | 36.27m |
| OCF | Operating Cash Flow |
|
$-24.71M | $-38.06M | $-50.87M | $-3.44M | $0.00M |
| FCF | Free Cash Flow |
|
$-24.73M | $-38.06M | $-51.45M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-1.72 | $-2.22 | $-2.24 | $-0.90 | $0.00 |